June 2019 Funding Opportunities and Announcements
Questions about this "funding flash"? Contact us at cancercenter@gwu.edu. View previous issues here. Interested in subscribing to future updates? Click the button below:
Damon Runyon Cancer Research Foundation Rachleff Innovation Award
This award is designed to provide funding to early career researchers who have an innovative idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research must be novel, creative, and have the potential for high impact in the cancer field.
Deadline: July 1, 2019
Amount and Project Period: $800,000 over 2-4 years (depending on stage)
Eligibility : Applicants must be conducting independent research at a U.S. research institution. Applicant must have received an MD, PhD or MD/PhD. Basic and translational/clinical projects will be considered.
Reviewers: Selection Committee
American Association for Cancer Research and Johnson & Johnson Lung Cancer Innovation Grants
This award will go to a multi-institutional team in support of a new idea and/or innovative approach that has direct application and relevance to lung cancer prevention and interception. The proposed research should be translational in nature and include a clinical component with an endpoint relevant to improving detection or treatment of lung cancer. Priority areas are noted in the RFP.
Deadline: July 19, 2019
Amount and Project Period: $1,000,000
Eligibility : At least two but no more than three co-applicants from distinct institutions are required. Eligible teams must be directed by a lead principal investigator and include up to two additional co-PIs. PIs must have a doctoral degree (PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) in the biomedical sciences or in a field applicable to health science research and not currently be a candidate for a further doctoral or professional degree. PIs must be affiliated with an academic, medical or research institution and be a member of AACR.
Contact: damin@gwu.edu
Reviewers: AACR Staff and External Reviewers
Leukemia and Lymphoma Society Career Development Awards
The Leukemia & Lymphoma Society supports multiple levels of career development awards annually, including: Fellow, Special Fellow, Scholar, and Scholar in Clinical Research.
Deadline: Multiple deadlines depending on eligibility and materials, starting September 1, 2019.
Amount and Project Period: $120,000-625,000 over 2-5 years
Eligibility : Career level eligibility requirements vary for each award level. Please see the RFP for specific requirements and subject matter focus for each award.
Reviewers: Undisclosed
Leukemia and Lymphoma Society Translational Research Program
The formation of the translational research program (TRP) was to foster collaboration between basic and clinical scientists with the intent of enhancing the transfer of basic research findings to clinical usefulness. Applications are sought proposing novel approaches to the prevention, diagnosis, or treatment of hematological malignancies and pre-malignant conditions. Proposals should be based on molecular, cellular, or integrated systems findings and be conceptually innovative. The application should have a clear plan for the eventual clinical translation of the studies proposed and results expected.
Deadline: August 31, 2019
Amount and Project Period: $600,000 over 3 years
Eligibility : Applicants must hold a PhD, MD, DVM or equivalent degree
Reviewers: Medical and Scientific Affairs Committee
Gilead Research Scholars: Hematology/Oncology
This program is designed to support innovative translational research projects in hematology/oncology, with a focus on hematologic malignancies, that can be either based around a clinical trail with strong correlative science or laboratory investigation.
Deadline: September 6, 2019
Amount and Project Period: $130,000 over 2 years
Eligibility : Applicants must hold an MD, DO, PhD, or equivalent degree at time of award and be within five years of initial appointment in association with an academic research institution. Applicant must have a research mentor with extensive experience in the field of hematology/oncology, with a focus on hematologic malignancies; be able to devote at least 50% time to the research project; and be able to complete the project within two years.
Contact: damin@gwu.edu
Pfizer Global Breast Cancer Research Grants
The intent of this program is to invite investigators from across the world to submit innovative proposals focusing on hormone receptor positive metastatic breast cancer and metastatic breast cancer. In addition, incorporation of the following into the proposed clinical study would be of interest: A correlative/biomarker component using paired biopsy samples, cfDNA assessment, predictive signatures beyond gBRCAmut in advanced breast cancer, or PK/PD biomarkers to explore potential mechanisms of resistance/response or synergistic effect.
Deadline: October 15, 2019
Amount and Project Period: Varies ($5M total available, 6-8 studies selected)
Eligibility : PIs must have a medical or postdoctoral degree. Both early career and experienced investigators are encouraged to apply, and consideration will be given to all proposals meeting research criteria.
Contact: damin@gwu.edu
Reviewers: Undisclosed independent review panel
Brander Beacons Breast and Prostate Cancer Research Grants
Brander Beacons Cancer Research (BBCR) is a private foundation seeking to accelerate research and innovation in breast and prostate cancer. BBCR injects critical funds in increments of $5,000 to $25,000 into programs most closely connected to increased cancer prevention, better treatment outcomes, better access, and, ultimately, a cure. Grants will be awarded to teams and projects that have potential to move the needle in their area of work or research. Funded projects will have clear goals, realistic plans to execute, and ways to measure success. A track record of taking on projects and meeting milestones in past work is helpful to share.
Deadline: Rolling
Amount and Project Period: $25,000
Eligibility : There are no career-level or citizenship restrictions listed with this opportunity
Reviewers: Undisclosed independent review panel